Comparative antimicrobial activity of trovafloxacin tested against 3049 streptococcus pneumoniae isolates from the 1997–1998 respiratory infection season

This publication has 21 references indexed in Scilit:

• In Vitro Evaluation of Sparfloxacin Activity and Spectrum Against 24,940 Pathogens Isolated in the United States and Canada, the Final Analysis
  Diagnostic Microbiology and Infectious Disease, 1998
• Efficacy of Trovafloxacin against Penicillin-Susceptible and Multiresistant Strains of Streptococcus pneumoniae in a Mouse Pneumonia Model
  Antimicrobial Agents and Chemotherapy, 1998
• Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin
  Antimicrobial Agents and Chemotherapy, 1997
• The chemistry and biological profile of trovafloxacin.
  Journal of Antimicrobial Chemotherapy, 1997
• Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae
  Antimicrobial Agents and Chemotherapy, 1997
• The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
  Clinical Microbiology & Infection, 1997
• The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System
  The Journal of Infectious Diseases, 1996
• Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
  The American Journal of Medicine, 1996
• In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis
  Antimicrobial Agents and Chemotherapy, 1995
• In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone
  Antimicrobial Agents and Chemotherapy, 1993